Summary
- Current Price
- As of today, CBIO price is $13.99, down -1.76% on
- Current Price All-Time High
- CBIO price is currently -99.46% below its historical high of $2,605.00 set on
- Market Cap
- CBIO current market cap is $520M, up +201.43% over the past 365 days
- Revenue
- CBIO current annual revenue is $10.84M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for CBIO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Crescent Biopharma, Inc. |
| Ticker | NASDAQ: CBIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | crescentbiopharma.com |
| Employees | 6 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $13.99 | |
| Price, 1D Change | -1.76% | |
| $520M | ||
| - | ||
| - | ||
| 0.88 | ||
| $10.84M | ||
| Revenue, 1Y Change | +100.00% | |
| -$14.78 | ||
| EPS, 1Y Change | +36.49% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:100 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GLYC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$14.78 | ||
| EPS Estimate | -$2.35 | N/A |
| EPS Est. Change | +84.08% | N/A |
| $10.84M | ||
| Revenue Estimate | $1.73M | N/A |
| Revenue Est. Change | -84.09% | N/A |
| Current Price | $13.99 | |
| Price Target | $28.00 | - |
| Price Tgt. Change | +100.14% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.03 | -$23.28 | -77,490.00% | |
| -$7.92 | -$14.78 | -86.77% | |
| -$2.35 | N/A | +84.08% | |
| -$2.63 | N/A | +82.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $8.57M | $10.84M | +26.51% | |
| $1.73M | N/A | -84.09% | |
| $4.79M | N/A | -55.87% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $13.99 | |
| $15.71 | ||
| $16.94 | ||
| $17.16 | ||
| $17.24 | ||
| -$0.69 | ||
| 0.88 | ||
| $1.46 | ||
| 31.36 | ||
| 71.31% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $10.84M | ||
| -$14.78 | ||
| $0.00 | ||
| 99.23% | ||
| -$152.63M | ||
| -1,407.52% | ||
| -$153.94M | ||
| -1,419.61% | ||
| -$152.55M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 6.56 | ||
| 6.56 | ||
| - | ||
| - | ||
| 8.41 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 43.73 | ||
| 3.26 | ||
| -2.08 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $199.01M | ||
| $213.19M | ||
| $240.29M | ||
| $236.66M | ||
| $37.28M | ||
| $36.07M | ||
| $1.64M | ||
| $435.00K | ||
| $10.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $164.79M | ||
| $163.39M | ||
| $84.00K | ||
| $25.39M | ||
| $84.00K | ||
| $0.00 | ||
| $2.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$71.53M | ||
| -$72.92M | ||
| $322.98M | ||
| $72.92M | ||
| -$144.45M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| Jefferies | ||
| HC Wainwright & Co. | ||
| Wedbush | ||
| Stifel |
Analyst sentiment
Institutional ownership
No data
Screeners with CBIO
FAQ
- What is the ticker symbol for Crescent Biopharma, Inc.?
- The ticker symbol for Crescent Biopharma, Inc. is NASDAQ:CBIO
- Does Crescent Biopharma, Inc. pay dividends?
- No, Crescent Biopharma, Inc. does not pay dividends
- What sector is Crescent Biopharma, Inc. in?
- Crescent Biopharma, Inc. is in the Healthcare sector
- What industry is Crescent Biopharma, Inc. in?
- Crescent Biopharma, Inc. is in the Biotechnology industry
- What country is Crescent Biopharma, Inc. based in?
- Crescent Biopharma, Inc. is headquartered in United States
- When did Crescent Biopharma, Inc. go public?
- Crescent Biopharma, Inc. initial public offering (IPO) was on January 10, 2014
- Is Crescent Biopharma, Inc. in the S&P 500?
- No, Crescent Biopharma, Inc. is not included in the S&P 500 index
- Is Crescent Biopharma, Inc. in the NASDAQ 100?
- No, Crescent Biopharma, Inc. is not included in the NASDAQ 100 index
- Is Crescent Biopharma, Inc. in the Dow Jones?
- No, Crescent Biopharma, Inc. is not included in the Dow Jones index
- When was Crescent Biopharma, Inc. last earnings report?
- Crescent Biopharma, Inc.'s most recent earnings report was on August 2, 2018
- When does Crescent Biopharma, Inc. report earnings?
- The date for Crescent Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CBIO Official Website crescentbiopharma.com
- CBIO Profile on Yahoo Finance finance.yahoo.com/quote/CBIO
- CBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cbio